ketoconazole has been researched along with Esophageal Diseases in 18 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Esophageal Diseases: Pathological processes in the ESOPHAGUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Esophageal candidiasis was diagnosed at endoscopy in two patients receiving omeprazole therapy." | 7.69 | Esophageal candidiasis following omeprazole therapy: a report of two cases. ( Chawla, LS; Jain, NP; Kumar, R; Sharma, M; Sood, A, 1995) |
| "In our study 77 AIDS patients suffering from oral and/or esophageal candidiasis were evaluated: 38 received fluconazole, 39 ketoconazole." | 7.68 | Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patients. ( Ancarani, F; Arzeni, D; Barchiesi, F; Branchesi, P; Crescenzi, G; Giacometti, A; Scalise, G, 1992) |
| "Three patients with esophageal candidiasis were treated with a new orally administered antifungal agent, ketoconazole." | 7.66 | Esophageal candidiasis: treatment with ketoconazole. ( Blackburn, WD; Gregory, DW; Madhavan, SV; Manske, CL; Stratton, CW, 1983) |
| "To determine the efficacy and toxicity of two systemically active antifungal agents in the treatment of buccal and oesophageal candidiasis 111 HIV-infected patients with microscopically-confirmed candidiasis were randomized to receive either 200 mg itraconazole once a day or 200 mg ketoconazole twice a day for 28 days in a double blind study." | 5.07 | Itraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV. ( Allan, M; Connolly, GM; Gazzard, BG; Midgley, J; Smith, DE, 1991) |
| "We conducted a randomized prospective study to compare the efficacy of oral miconazole and ketoconazole in the treatment of candida esophagitis in acquired immune deficiency syndrome (AIDS) patients in Haiti." | 5.06 | Treatment of candida esophagitis in AIDS patients. ( DeHovitz, J; Deschamps, MM; Johnson, WD; Pape, JW; Thomas, F; Verdier, RI, 1988) |
| "Esophageal candidiasis was diagnosed at endoscopy in two patients receiving omeprazole therapy." | 3.69 | Esophageal candidiasis following omeprazole therapy: a report of two cases. ( Chawla, LS; Jain, NP; Kumar, R; Sharma, M; Sood, A, 1995) |
| "In our study 77 AIDS patients suffering from oral and/or esophageal candidiasis were evaluated: 38 received fluconazole, 39 ketoconazole." | 3.68 | Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patients. ( Ancarani, F; Arzeni, D; Barchiesi, F; Branchesi, P; Crescenzi, G; Giacometti, A; Scalise, G, 1992) |
| "We describe a patient with the acquired immunodeficiency syndrome who had persistent oral esophageal pseudomembranous candidiasis clinically refractory to nystatin, clotrimazole, and ketoconazole." | 3.68 | Treatment of refractory oral candidiasis with fluconazole. A case report. ( Chafey, S; Franker, C; Hardy, WD; Lucatorto, FM, 1991) |
| "Three patients with esophageal candidiasis were treated with a new orally administered antifungal agent, ketoconazole." | 3.66 | Esophageal candidiasis: treatment with ketoconazole. ( Blackburn, WD; Gregory, DW; Madhavan, SV; Manske, CL; Stratton, CW, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (38.89) | 18.7374 |
| 1990's | 11 (61.11) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rutgeerts, LJ | 1 |
| Symoens, J | 1 |
| Gregory, DW | 1 |
| Blackburn, WD | 1 |
| Madhavan, SV | 1 |
| Manske, CL | 1 |
| Stratton, CW | 1 |
| Murphy, JF | 1 |
| Jones, M | 1 |
| Thompson, EN | 1 |
| Force, RW | 1 |
| Nahata, MC | 1 |
| Sood, A | 1 |
| Sharma, M | 1 |
| Jain, NP | 1 |
| Chawla, LS | 1 |
| Kumar, R | 1 |
| Taylor, CB | 1 |
| Finlay, R | 1 |
| Richardson, C | 1 |
| Bunting, P | 1 |
| Welch, J | 1 |
| Cartledge, JD | 1 |
| Midgley, J | 2 |
| Petrou, M | 1 |
| Shanson, D | 1 |
| Gazzard, BG | 2 |
| Fortun Abete, J | 1 |
| Laing, RB | 1 |
| Brettle, RP | 1 |
| Leen, CL | 1 |
| Barchiesi, F | 1 |
| Giacometti, A | 1 |
| Arzeni, D | 1 |
| Branchesi, P | 1 |
| Crescenzi, G | 1 |
| Ancarani, F | 1 |
| Scalise, G | 1 |
| Barantsevich, EP | 1 |
| Karaev, ZO | 1 |
| Smith, DE | 1 |
| Allan, M | 1 |
| Connolly, GM | 1 |
| Lucatorto, FM | 1 |
| Franker, C | 1 |
| Hardy, WD | 1 |
| Chafey, S | 1 |
| Kitchen, VS | 1 |
| Savage, M | 1 |
| Harris, JR | 1 |
| Tindall, B | 1 |
| Hing, M | 1 |
| Edwards, P | 1 |
| Barnes, T | 1 |
| Mackie, A | 1 |
| Cooper, DA | 1 |
| Naito, Y | 1 |
| Yoshikawa, T | 1 |
| Oyamada, H | 1 |
| Tainaka, K | 1 |
| Morita, Y | 1 |
| Kogawa, T | 1 |
| Sugino, S | 1 |
| Kondo, M | 1 |
| Deschamps, MM | 1 |
| Pape, JW | 1 |
| Verdier, RI | 1 |
| DeHovitz, J | 1 |
| Thomas, F | 1 |
| Johnson, WD | 1 |
| Lee, WM | 1 |
| Holley, HP | 1 |
| Stewart, J | 1 |
| Galbraith, GM | 1 |
1 review available for ketoconazole and Esophageal Diseases
| Article | Year |
|---|---|
[Diagnosis, treatment and prevention of infections caused by fungi in HIV-positive patients].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Cand | 1995 |
3 trials available for ketoconazole and Esophageal Diseases
| Article | Year |
|---|---|
Salivary concentrations of ketoconazole and fluconazole: implications for drug efficacy in oropharyngeal and esophageal candidiasis.
Topics: Administration, Oral; Adult; Candida albicans; Candidiasis; Chromatography, High Pressure Liquid; Cr | 1995 |
Itraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV.
Topics: Antifungal Agents; Candidiasis; Candidiasis, Oral; Double-Blind Method; Esophageal Diseases; Female; | 1991 |
Treatment of candida esophagitis in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Candidiasis; Clinical Trials as Top | 1988 |
14 other studies available for ketoconazole and Esophageal Diseases
| Article | Year |
|---|---|
Successful treatment of chronic esophageal candidosis with oral ketoconazole.
Topics: Administration, Oral; Aged; Antifungal Agents; Candidiasis; Chronic Disease; Esophageal Diseases; Hu | 1982 |
Esophageal candidiasis: treatment with ketoconazole.
Topics: Administration, Oral; Adult; Candidiasis; Child; Esophageal Diseases; Female; Humans; Ketoconazole; | 1983 |
Oesophageal candidiasis and croup in a child with defective neutrophil motility.
Topics: Candidiasis; Chemotaxis, Leukocyte; Croup; Esophageal Diseases; Female; Humans; Immunologic Deficien | 1984 |
Esophageal candidiasis following omeprazole therapy: a report of two cases.
Topics: Abdominal Pain; Adolescent; Adult; Candidiasis; Esophageal Diseases; Female; Gastritis; Humans; Keto | 1995 |
Rationalizing prescribing for oral and oesophageal candidiasis.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Candidiasis, Oral; Drug Costs | 1996 |
Unresponsive HIV-related oro-oesophageal candidosis--an evaluation of two new in-vitro azole susceptibility tests.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistanc | 1997 |
Clinical predictors of azole resistance, outcome and survival from oesophageal candidiasis in AIDS patients.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Body Weight; Candidiasis; CD4 Lymphocyte C | 1998 |
Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patients.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Candidiasis; Candidiasis, Oral; Esophageal Disea | 1992 |
[Esophageal candidiasis in patients with hemoblastosis].
Topics: Candidiasis; Diagnosis, Differential; Esophageal Diseases; Female; Humans; Ketoconazole; Leukemia, M | 1992 |
Treatment of refractory oral candidiasis with fluconazole. A case report.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Candida albicans; Candidiasis, Oral; Clot | 1991 |
Candida albicans resistance in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Candidiasis, Oral; Drug Resistance, Microbial; Esophageal | 1991 |
Severe clinical manifestations of primary HIV infection.
Topics: Adult; Candidiasis; CD4-Positive T-Lymphocytes; Esophageal Diseases; HIV Infections; Humans; Ketocon | 1989 |
Esophageal candidiasis.
Topics: Amphotericin B; Autoimmune Diseases; Candidiasis; Esophageal Diseases; Esophagoscopy; Female; Humans | 1988 |
Refractory esophageal candidiasis associated with a low molecular weight plasma inhibitor of T-lymphocyte function.
Topics: Adult; Candidiasis; Esophageal Diseases; Female; Humans; Immunologic Deficiency Syndromes; Interleuk | 1986 |